Drug discovery and computational strategies in the multitarget drugs era
Viana, Jéssika de Oliveira, Félix, Mayara Barbalho, Maia, Mayara dos Santos, Serafim, Vanessa de Lima, Scotti, Luciana, Scotti, Marcus Tullius
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
The pharmaceutical industry is increasingly joining chemoinformatics in the search for the development of new drugs to be used in the treatment of diseases. These computational studies have the advantage of being less expensive and optimize the study time, and thus the interest in this area is increasing. Among the techniques used is the development of multitarget directed ligands (MTDLs), which has become an ascending technique, mainly due to the improvement in the quality of treatment involving several drugs. Multitarget therapy is more effective than traditional drug therapy that emphasizes maximum selectivity for a single target. In this review a multitarget drug survey was carried out as a promising strategy in several important diseases: neglected diseases, neurodegenerative diseases, AIDS, and cancer. In addition, we discuss Computer-Aided Drug Design (CADD) techniques as a tool in the projection of multitarget compounds against these diseases.
- Computational drug discovery for the Zika virus
- New Prospects and Strategies for Drug Target Discovery in Neurodegenerative Disorders
- Codominant interference, antieffectors, and multitarget drugs
- Computational Analysis of Plasmodium falciparum Metabolism: Organizing Genomic Information to Facilitate Drug Discovery
- Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors